Introduction
Myostatin, a new member of the TGF-β superfamily is predominantly expressed in developing and adult skeletal muscle. Myostatin-null mice display a two to three-fold increase in skeletal muscle mass, due to both hyperplasia (increase in the number of fibers) and hypertrophy (increase in fiber thickness) (26) . Naturally occurring mutations in the myostatin gene coding sequence in Belgian Blue and Piedmontese cattle breeds result in the heavy muscle phenotype (14, 22, 27) . Hence, myostatin functions as a negative regulator of muscle growth.
Myostatin expression is detected in myogenic precursors during early embryogenesis, and the expression continues in postnatal skeletal muscle (22, 26) . Changes in muscle mass have been shown to be related to changes in myostatin expression. Recently, Roth et al (2003) (32) reported that myostatin mRNA levels are reduced in response to heavy-resistance strength training in humans. On the other hand, higher levels of circulatory and muscle myostatin have been observed in humans suffering with AIDS related muscle wasting or age-associated sarcopenia (13, 25). Furthermore, chronic underfeeding in sheep and hind-limb suspension in rats resulted in increased levels of myostatin (6, 21, 42) . Collectively, these results and other reports indicate that myostatin expression is regulated at the transcription level.
Although the functional role of myostatin in controlling muscle mass has been delineated, much remains to be learnt about the regulation of myostatin gene at the transcription level. Recently, two studies have analysed the human and bovine myostatin promoter (24, 37) . The 5' upstream regulatory sequences from human, bovine, porcine and murine myostatin genes have considerable sequence homology and share many transcription factor binding motifs (37) . The similarity between the human and bovine myostatin gene upstream region (1.6 kb) was 79% and that 4 between the bovine and murine was 68%. Among the factors influencing the human myostatin promoter activity are glucocorticoid responsive elements, which can upregulate the transcriptional activity of the myostatin promoter in response to dexamethasone treatment (24) . In addition, multiple E-boxes, the consensus binding sequence of myogenic regulatory factors, have been identified in the myostatin promoter from different species (37) . So far these studies have been performed in cell cultures which are more or less a homogeneous population. Skeletal muscles are heterogeneous with respect to contractile properties, the fast and slow fiber types, which have distinct gene expression profiles (33) . Muscle fiber types, based on the MHC isoform expression have been classified as i) slow type I; ii) intermediate type IIA; iii) fast type IIX; and iv) fast type IIB. Myostatin expression is seen preferentially in the type IIB fibers (6) . Similarly, MyoD expression predominates in fast type IIB/IIX muscle fibers (31) . Furthermore, myostatin gene expression has been shown to be induced by MyoD (37) , raising the possibility that the myostatin promoter may be responding to MyoD activity specifically in type IIB fibers. Hence, the purpose of this study was to determine the critical cis-acting regions within the myostatin promoter that drive fiber-type-specific expression of this gene in vivo. In this report, the somatic transfer of naked DNA was used to analyse the myostatin promoter activity, as this method offers a simple and time effective way of carrying out in vivo analysis of muscle-specific regulatory regions (36, 43) in a fiber-type specific manner (9, 38) . The results obtained indicate that, in vivo, the promoter activity is species specific, as observed from the weaker activity of bovine myostatin promoter in mouse as compared to the murine promoter. The results of the in vivo experiments also show that E-box E5 of the murine myostatin promoter plays a crucial role in the regulation of the promoter activity. Furthermore, we demonstrate that among the MRFs, MyoD preferentially activates the murine myostatin promoter and this overlaps with the expression of the reporter activity in type IIB fibers in vivo.
Materials and Methods
Cloning of the murine myostatin promoter fragments A 2.5kb and a 1.7kb fragment of the myostatin promoter were amplified by PCR using genomic murine DNA as a template. Wild-type and mutated 5' truncation constructs containing the various E-boxes were also generated by PCR using mouse genomic DNA as a template. Primer sequences and combinations are shown in Table   1 . The amplification was carried out using Taq polymerase (Invitrogen) in buffer 
Transfections and Luciferase Assays
C2C12 cells were routinely cultured in Dulbecco's Modified Eagle Medium (D-MEM; Gibco-BRL, USA), buffered with NaHCO 3 (41.9 mmol/l; Sigma, St Louis, MO) and gaseous CO 2 . Phenol red (7.22 nmol/l; Sigma) was used as a pH indicator.
Penicillin (1 x 10 5 IU/l; Sigma), streptomycin (100 mg/l; Sigma) and foetal bovine serum (FBS, 10%, Gibco-BRL, USA) were routinely added to the media. 
Gel mobility shift assays
Recombinant MyoD, Myf5 and E47 were expressed and purified from E.coli as described previously (37) . Plasmids pQT-MyoD and pQT-E47 were kind gifts from all the mice were killed at day 7 after naked DNA injection and the muscles (twelve muscles/construct) processed for total luciferase activity.
Total muscle luciferase and protein assay
Each muscle was frozen in liquid nitrogen and ground to a fine powder. The material was resuspended in 1ml of cell lysis buffer (25mM Tris-phosphate (pH 7.8), 2mM
glycerol, 1% Triton X-100), and processed as described for cell lysates. Ten microlitres of undiluted muscle extract was used for luciferase assay. Five microlitres
(1:100 dilution in lysis buffer) of muscle extract was used for estimating total protein concentration by Biorad protein assay reagent (Bio-Rad Lab). The protein estimates were used to normalise the luciferase readings.
Immunocytochemistry
The muscles from mice injected with 2.5P, tE5 or pGL3-B DNA were collected and frozen in isopentane chilled in liquid nitrogen. Cryosections were cut at 10µm and the slides frozen at -20 o C until used.
The sections were permeabilized in PBS, 0.1% Triton X-100 for 30min at room temperature and incubated with primary anti-luciferase antibody (Promega) at 1:50 dilution in PBS, 5% normal goat serum, 1% BSA, 0.1% Triton X-100 overnight at at room temperature. Slides were washed in PBS, blocked in PBS, 0.1% Triton X-100, 5% normal sheep serum for 30min at room temperature. Slides were then incubated with biotinylated secondary antibody (Amersham, UK) and treated as described above. Control sections were incubated with either no primary antibody or mouse control IgG and then processed as described above.
Histochemical fiber typing of the muscle sections
For histochemical fiber typing of the muscle, standard alkali ATPase method was used, as described by Guth and Samaha (15, 16) . In summary, serial sections were 
Statistics
Normalised luciferase values from in vivo experiments were evaluated using analysis of variance (ANOVA) of the log transformed values in GenStat 6 software. Selected comparisons were tested for significance using Student's t-test and the pooled standard deviation. All in vitro assays were analysed using Student's t-test.
Results

Transcription factor binding sites in the murine myostatin gene promoter
Sequence analysis of the 2.5kb fragment of the murine myostatin promoter using
MatInspector identified a series of muscle-specific transcription factor binding sites.
As seen in Figure 1 , one MEF2 site is present within 1.3kb of the promoter and seven E-boxes motifs are present in the 2.5kb region. The E-boxes in the murine promoter are arranged in clusters; the first cluster contains two E-boxes with identical CACTTG sequence (E1 and E2); the second cluster contains another two E-boxes with the sequence CAAATG (E3 and E4); E-box E5 does not appear to be a part of any cluster, while the last cluster contains E-boxes E6 and E7. 
Analysis of the murine myostatin promoter activity in myoblasts
An extensive in vitro analysis of the murine myostatin promoter activity was performed before the in vivo characterization of the promoter. A series of truncation constructs containing different numbers of E-boxes were generated and transfected into C2C12 cells. As shown in Figure 2 , the effect of the E-boxes seems to be additive, as the activity of the promoter increases with the number of E-boxes present in the construct. Moreover, inclusion of E-box E5 increases the reporter gene activity to the same level observed with construct 2.5P, which includes E-boxes E6 and E7.
This suggests that the presence of the first five E-boxes, and in particular E-box E5, is sufficient to render maximal promoter activity in C2C12 cells.
Since MRFs are known to bind to E-boxes and induce the promoter activity (1, 2, 8), the murine 1.7P promoter construct, which contains the first five E-boxes, was cotransfected with either MyoD or Myf5 expression vector into C2C12 cells, and the reporter gene activity was determined. The results show that both factors induced the activation of the myostatin promoter (Fig. 3) . However, while MyoD increased the promoter activity by over 6-fold, Myf5 co-transfection led only to a 2-fold increase, suggesting that MyoD preferentially regulates myostatin promoter activity.
Binding of MyoD/E47 and Myf5/E47 to E-box E5 in vitro
To confirm that MyoD and Myf5 bind to E-boxes in vitro, we performed gel shift assays using the sequences containing the wild type (E5wt) or mutated (E5mut) E-box E5 as probes. Although in vitro both MyoD and Myf5 can bind to E-boxes as homodimers, in vivo they form heterodimers with E proteins such as E12 or E47. As shown in Figure 4A , MyoD alone was able to form a complex with E5wt (lane 1), but a higher intensity of complex formation was observed when the MyoD/E47
heterodimer was present (Fig. 4A, lane 2) . On the other hand, no complex was formed with the E5wt probe and Myf5 alone (Fig. 4A, lane 3 ), but addition of E47 led to the formation of a complex (lane 4). These results suggest that while MyoD can bind to an E-box as a homodimer in vitro, Myf5 is only able to bind as a heterodimer.
Significantly lesser complexes were formed when the E5mut probe was used (Fig. 4A , lanes 5 to 8), suggesting that the binding of MyoD and Myf5 to E-box E5 is dependent on its sequence integrity.
To investigate the binding affinity of MyoD/E47 and Myf5/E47 further, EMSAs were performed in which a limiting amount of E5wt probe was incubated with decreasing concentrations of MyoD/E47 or Myf5/E47 (550ng to 33pg). A representative 13 autoradiogram of the results for MyoD/E47 and Myf5/E47 can be seen in Figure 5A and B, respectively. The relative optical density of free DNA was measured and subtracted from the protein-bound DNA and the values used for the calculation of the K D (app) as described in materials and methods. The K D (app) values for the binding of MyoD/E47 and Myf5/E47 to the probe were 0.1 and 0.2µM respectively.
In vivo activity of the myostatin promoter
In order to analyse the activity of the myostatin promoter in vivo, two constructs of approximately the same lengh, the murine 1.7P and the bovine 1.6b construct, were injected into the quadriceps femoris muscle of mice. Control mice were injected with the promoterless reporter gene vector pGL3-B. The mice were killed on day 3 or 7
after injection and the luciferase activity was determined. The results demonstrate that the preferred time to obtain maximal expression was at day 7 after injection, as the average expression was over 3.5-fold higher than that obtained at day 3 (Fig. 6) .
Therefore, for all subsequent in vivo experiments, the muscles were recovered 7 days after naked DNA injection. Interestingly, despite inducing comparable levels of luciferase activity in murine myoblasts (data not shown) (37), the bovine myostatin promoter construct activity was significantly weaker than that of the murine construct in vivo (Fig. 6) .
Analysis of the murine myostatin promoter activity in vivo
As described above (Fig. 2) , presence of the 5 E-boxes (E1-E5) is essential for the maximal activity of the murine myostatin promoter in vitro. Furthermore, EMSA results revealed that mutation of E-box E5 disrupted the binding of MyoD and Myf5 to this site (Fig. 4A) . In order to determine the significance of the E-boxes in vivo, E-box truncation and mutation constructs, and the 2.5P construct, were injected into the quadriceps of C57BL/10 mice and the reporter luciferase activity was determined.
While truncation constructs tE3 and tE4 displayed significantly lower levels of promoter activity as compared to the 2.5P construct, the expression level of construct tE5 was as high as the 2.5P construct (Fig. 7) . This result suggested the possibility that a regulatory element present within the 775bp between tE4 and tE5 constructs was responsible for the maximal activity present in construct tE5. In order to
determine if E-box E5 was this crucial element, a series of mutation constructs were generated and their activity measured in vivo. The activity of the constructs containing mutated E-boxes was dramatically reduced when compared with their wild type counterparts. Construct mE3 displayed a 74% decrease in its activity, and constructs mE4 and mE5 had their activity reduced by 83% when compared to constructs tE3, tE4 and tE5 respectively (Fig. 7) . Interestingly, the activity of the E5 mutated construct was comparable to that of the wild type E3 and E4 constructs, which lack Ebox E5. This suggests that the presence of a functional E-box E5 is sufficient to restore maximal promoter activity in vivo, confirming the in vitro results (transfections and EMSAs) and supporting the idea that E-box E5 is a preferential binding site for both MyoD and Myf5.
The 2.5kb of myostatin promoter drives the expression of the reporter gene in a fiber type specific manner
Myostatin expression has been associated with fast twitch muscle fibers (23), in particular type IIb fibers (6) . Hence, to determine if 2.5P and tE5 were also able to drive the reporter gene expression in a fiber type specific manner, quadriceps muscle of C57BL/10 mice were injected with construct 2.5P, or tE5 or pGL3-B control 15 vector. The 2.5P and tE5 constructs were chosen for this experiment since they demonstrate similar level of luciferase reporter activity both in vivo and in vitro.
The muscles were recovered 7 days after the DNA injection and the tissue processed as described in the materials and methods. The resulting tissue sections were immunostained with various primary antibodies. Sections derived from the mice injected with 2.5P constructs were positive for luciferase expression (Fig. 8A) , while sections from muscle injected with pGL3-B display no fluorescence when incubated with anti-luciferase antibody (data not shown). Serial sections from mice injected with 2.5P construct were also immunostained with anti-slow type I fiber and anti-fast type II fiber antibodies and the results compared with that for luciferase antibody. The fibers positive for luciferase expression (Fig. 8A , arrow) co-localize with the fibers reactive with anti-fast type II fiber antibody (Fig. 8B ), but not with fibers reactive with anti-slow type I antibody (Fig. 8C, star) . This indicates that the myostatin promoter is restricting the expression of the reporter gene to fast muscle fibers.
However, the anti-fast type II antibody N1.551 has been described as an anti-fast type IIa in rats (41) . In order to determine if any of the fibers detected by N1.551 were type IIb, histochemical fiber typing was performed. The results show that most of the fibers positive for luciferase expression are dark stained fibers, expected to be type IIb fibers (Fig. 8D, arrow) . Control sections treated with no primary antibody or with mouse IgG did not display any fluorescence (data not shown). Interestingly, tE5 did not display fiber type specific expression when injected into the muscle. As seen in figure 9A , a diffuse pattern of expression was observed when anti-luciferase antibody was used, and the luciferase positive fibers co-localized with fibers reactive with antislow type I (Fig. 9B, star) as well as anti-fast type II (Fig. 9C, arrow) antibodies.
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Although able to express level of reporter gene activity similar to wild type 2.5P construct both in vivo and in vitro, tE5 is unable to confer fiber type specificity.
Discussion
Myostatin is predominately expressed in skeletal muscle, and is a known negative regulator of skeletal muscle development and growth. Although the transcriptional regulation of myostatin has been demonstrated in the myoblast cell lines (24, 37) , no information is available on the regulatory elements controlling myostatin gene expression in skeletal muscle in vivo. In the present study, the activity of the myostatin promoter was analyzed in vivo via somatic gene transfer, to determine the species specific and fiber type specific expression of the myostatin gene.
Murine versus bovine myostatin promoter activity in mouse skeletal muscle
To date, the 5' upstream sequences of the myostatin gene have been isolated from cattle, pig, mouse and human (GenBank accession nos. AF348479, AF093798, AX139025 and AX058992 respectively). In this communication, the activity of promoter constructs from two different species, murine and bovine, were examined in murine skeletal muscle. Interestingly, a comparison of the activity of the bovine and the murine myostatin promoter in vivo revealed that the bovine promoter activity is significantly weaker than that of the murine promoter (Fig. 6) . However, similar levels of reporter gene activity for these constructs were seen in C2C12 myoblasts.
Previously it has been reported that 1.6 kb of bovine promoter is sufficient for the maximal promoter activity (37) . The murine and bovine promoters share 68%
homology within this region. However, the two promoters also display some distinct features such as the number and arrangement of the E-boxes, the consensus binding sites for MRFs, which are critical for muscle specific gene expression. As the in vivo system is more sensitive, these genetic differences between the bovine and the murine promoters become more relevant. Furthermore, the murine sequence has a polyA tract (A 20 ) between E-boxes E4 and E5 which is not present in the bovine sequence. PolyA sequences have been associated with DNA spatial conformation and it has been argued that DNA curvature between motifs can lead to more efficient dimerization of proteins by bringing factors into proximity with each other (40) . The presence of a polyA tract in the murine sequence could lead to a specific DNA conformation, and therefore contribute to the level of promoter activity in vivo. Together, these differences might be sufficient to impair the ability of the bovine promoter to induce the reporter gene expression in mouse skeletal muscle to the same levels as that in C2C12 cells. Thus species specificity is a factor to be considered when generating transgenic mice for a particular gene promoter.
MyoD and Myf5 activate myostatin promoter differentially
MRFs, in particular MyoD and Myf5, regulate their target genes by binding to Eboxes in the promoter region (1, 2, 8) . Sequence analysis of the 2.5 kb fragment of the murine promoter revealed the presence of seven E-box motifs (Fig. 1) . However, analysis of the murine myostatin promoter activity in C2C12 cells indicated that the first five E-boxes, in particular E-box E5, are sufficient for its maximal activity (Fig.   2) . Furthermore, analysis of the induction of the murine promoter activity by these two MRFs revealed that Myf5 is a weak activator, while MyoD appears to be a potent activator of promoter activity (Fig. 3) . Importantly, analysis of the E-boxes activity in vivo confirmed the results obtained in vitro, where the presence of E-box E5 was sufficient to restore maximal promoter activity ( Fig. 2 and 7) . Moreover, mutation of E-box E5 decreased the promoter activity (by 83%) to levels comparable to constructs lacking this E-box (Fig. 7) , confirming the importance of the E-box E5 for the activity of the murine promoter.
The MRFs have been shown to bind to an E-box in complex with ubiquitous helixloop-helix E-proteins including E12 and E47. It has been suggested that MyoD/E47
heterodimers cooperate in binding to promoters containing multiple E-boxes (4) , and that MyoD/E12 heterodimer binding affinity to DNA targets containing multiple Eboxes is much higher than interactions with targets containing a single E-box (10). On the other hand, under certain experimental conditions a single E-box motif is capable of binding a specific MRF and confer activity (12, 35) .
The results reported here indicate that MyoD preferentially activates the myostatin promoter activity, which is consistent with the previous study (37) . To further investigate the basis of higher activation of the promoter by MyoD as compared to Myf5, we examined the DNA binding of MyoD/E47 and Myf5/E47 to E-box E5 of the murine myostatin promoter in vitro. The E-box E5 was chosen for the EMSA experiments on the basis of its crucial nature in the activation of the myostatin promoter ( Fig. 2 and 7) . Our in vitro results indicate a difference, although small, between the binding affinity of MyoD/E47 to the DNA when compared to that of Myf5/E47. The relatively higher binding affinity of MyoD could be contributing to the stronger activation of the myostatin promoter by MyoD as compared to that by Myf5 in the transient transfections (Fig. 3) . Furthermore, the presence of more than one E-box in the transfected constructs may also help the activation by MyoD.
Previously, the murine sarcoma virus (MSV) promoter-enhancer containing six Eboxes has been tested for MyoD/E12 and Myogenin/E12 interactions. This report demonstrated that DNA sequences containing multiple E-boxes have higher binding affinity to MyoD/E12 and Myogenin/E12 DNA than DNA fragments containing a single E-box (10). Further, it was shown that MyoD/E12 has higher affinity for the MSV enhancer and bound to the DNA with higher cooperativity than Myogenin/E12.
Based on these results, it was postulated that multiple E-boxes in the promoter region could contribute not only to high affinity DNA binding but also confer MyoD and Myogenin DNA recognition specificity (10).
Myostatin promoter activity is fiber type specific
Since myostatin expression has been described in association with fast-twitching fibers (6, 23), we assessed the capacity of myostatin promoter constructs 2.5P and tE5
to render fiber-type specificity to the reporter gene expression in vivo. Earlier, Corin et al (1995) (9) showed the expression of injected TnIs/luciferase constructs in slow fibers, and inferred that chromosomal integration was not a primary requirement to achieve appropriate fiber-type-specific gene regulation. It was postulated that the DNA sequence of the injected promoter conveyed the necessary information for fibertype-specific TnIs gene expression in the adult skeletal muscle. Similarly, Swoap (1998) (38) reported the fast fiber-type-specific expression of the MHC IIB promoter in vivo using somatic gene transfer. The results of our study demonstrated that the 2.5P fragment of the murine myostatin promoter is sufficient to drive the expression of the reporter gene in a fiber-type specific manner in 4 week old mice. Interestingly, MyoD has also been shown to be preferentially expressed in fast-twitching fibers (19, 20) , and myostatin and MyoD expression overlap during embryogenesis (30) .
Furthermore, although the levels of MyoD decrease in the adult muscle, it is still highly expressed in 4 week old mice (28), coinciding with the manifestation of fibertype specific properties, mainly the switch from MyCH-emb and -neo to MyCH-IIA, IIB and IIX that develop by 3 to 4 weeks of age in mice (5) . Also, Wheeler et al (1999) (43) demonstrated that the presence of a functional E-box within the MyHC-20 IIB promoter is essential for the expression of the reporter gene in vivo in a fiber-type specific manner. These results also support our finding that the absence of the sequences upstream of E-box E5 in tE5 leads to loss of fiber-specific expression as evident from the expression of luciferase activity in both type I and type II fibers (Fig   9) . It is noteworthy that the sequences upstream of E5 E-box contain two additional E-boxes, E6 and E7, which are present in the 2.5P construct (Fig 1A) . 
